COR vs MCK
COR: Cencora is a critical link in the global healthcare supply chain, providing pharmaceutical distribution, commercialization services, and specialty drug support to ensure patients have access to life-saving medications. MCK: A global leader in pharmaceutical distribution and healthcare technology services, connecting biopharma, providers, and patients to improve care outcomes.
Side-by-side fundamentals
| Metric | COR | MCK | Edge |
|---|---|---|---|
| Price as of 2026-08-21 close | $318.04 | $858.90 | |
| Market cap as of 2026-08-24 | $60.7B | $100.1B | |
| P/E as of 2026-08-24 | 22.54 | 21.89 | MCK lower |
| PEG as of 2026-08-24 | 2.26 | 1.70 | MCK lower |
| Net margin as of 2026-08-24 | +0.8% | +1.1% | MCK higher |
| Gross margin as of 2026-08-24 | +4.0% | +3.6% | COR higher |
| Operating margin as of 2026-08-24 | +0.9% | +1.6% | MCK higher |
| ROE as of 2026-08-24 | +106.4% | +39.4% | COR higher |
| ROA as of 2026-08-24 | +3.3% | +5.4% | MCK higher |
| Debt / equity as of 2026-08-24 | 3.84 | 1.29 | MCK lower |
| Revenue growth (YoY) as of 2026-08-24 | +5.1% | +8.8% | MCK higher |
| Revenue CAGR (3y) SEC XBRL | +10.4% | +13.4% | MCK higher |
| Dividend yield as of 2026-08-24 | +1.0% | +0.5% | COR higher |
| Dividend streak (yrs) SEC XBRL | 4 | 5 | MCK higher |
| Beta as of 2026-08-24 | 0.57 | 0.30 | |
| 1-year return as of 2026-08-21 close | +4.9% | +21.7% | MCK higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.